Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Immunologic Research|November 23, 2022
Immunotherapeutic effects of intratumorally injected Zymosan-Adenovirus conjugates encoding constant active IRF3 in a melanoma mouse modelMaggie Musick, Xianzhong YuImmunologic Research|April 29, 2022
Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factorsMaggie Musick, Xianzhong YuPlos One|July 26, 2018
Lentiviral delivery of novel fusion protein IL12/FasTI for cancer immune/gene therapyXi Yang, Xianzhong Yu, Yanzhang WeiOncology Reports|January 19, 2017
MICA/IL-12: A novel bifunctional protein for killer cell activationAshlee Tietje, Xi Yang, Xianzhong Yu, et al.International Journal of Oncology|April 16, 2016
Mouse interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immuno/gene therapyXi Yang, Ashlee H Tietje, Xianzhong Yu, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|November 16, 2011
Lentiviral-mediated RNAi knockdown yields a novel mouse model for studying Cyp2b functionBasma Damiri, Eric Holle, Xianzhong Yu, et al.Oncology Letters|June 25, 2014
A biotin-streptavidin-biotin bridge dramatically enhances cell fusionJinhua Li, Xianzhong Yu, Thomas E Wagner, et al.Human Vaccines & Immunotherapeutics|December 9, 2014
Novel dendritic cell-based vaccination in late stage melanomaErika J Schneble, Xianzhong Yu, T E Wagner, et al.BMC Cancer|December 18, 2008
Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunityAlexander Y Wagner, Eric Holle, Lori Holle, et al.International Journal of Oncology|February 10, 2004
Bcl-2 targeting siRNA expressed by a T7 vector system inhibits human tumor cell growth in vitroLori Holle, Labri Hicks, Wendy Song, et al.Pageof 5